<?xml version="1.0" encoding="UTF-8"?>
<p>WHO has identified resistance to antimalarial drugs, particularly artemisinin and the partner medications that are the mainstay of treatment for uncomplicated 
 <italic>Plasmodium falciparum</italic> malaria, as a major threat to malaria control. Such resistance has already been reported in the Greater Mekong subregion of Southeast Asia [
 <xref rid="B3-tropicalmed-04-00053" ref-type="bibr">3</xref>], underscoring the need for new antimalarial drugs with alternate mechanisms of action.
</p>
